Westside Current on MSN5d
Breakthrough in Long COVID: An investigator-initiated trial (IIT) with Hyundai Bioscience's Xafty by UCSDHyundai Bioscience USA announced that it has signed an MOU with the University of California San Diego (UCSD) to conduct an ...
Hyundai Bioscience presents development updates of its broad-spectrum antiviral at the "Disease Prevention and Control Summit ...
Its pipeline includes ANA001, a proprietary oral niclosamide formulation, Gemcabene, which is assessed as an acute indication for COVID-19, NB-01, a treatment for painful diabetic neuropathy ...
The study recruited outpatients with mild to moderate COVID-19 to determine whether a widely available repurposed therapeutic, niclosamide, reduced SARS-CoV-2 oropharyngeal (OP) and fecal shedding and ...
Discover all the brand names or Trade names of generic drug called Niclosamide. This serves as a crucial reference for healthcare professionals, patients, caregivers, and anyone looking to ...
The firm is involved in a therapeutic development pipeline populated with multiple clinical stage programs built around its proprietary technologies, such as Niclosamide, an oral small molecule ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback